Kenjiro Namikawa
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Nonmelanoma Skin Cancer Studies, CAR-T cell therapy research
Most-Cited Works
- → Targeted Therapy and Immunotherapy for Melanoma in Japan(2019)165 cited
- → Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy(2016)158 cited
- → Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients(2020)137 cited
- → Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma(2019)107 cited
- → Characteristics of melanoma in Japan: a nationwide registry analysis 2011–2013(2017)96 cited
- → Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study(2018)72 cited
- → Combination chemotherapy for metastatic extramammary Paget disease(2013)69 cited
- → Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease(2013)67 cited
- → Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma(2011)60 cited
- → Correlation between cutaneous adverse events and prognosis in patients with melanoma treated with nivolumab: A single institutional retrospective study(2020)56 cited